Free Trial

Bank of New York Mellon Corp Trims Stock Position in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Bank of New York Mellon Corp decreased its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 5.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 540,935 shares of the health services provider's stock after selling 29,805 shares during the quarter. Bank of New York Mellon Corp owned 0.96% of Maximus worth $36,886,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in MMS. Norges Bank purchased a new stake in Maximus in the 4th quarter worth $71,443,000. SG Capital Management LLC purchased a new stake in shares of Maximus in the fourth quarter worth about $30,285,000. Federated Hermes Inc. boosted its stake in Maximus by 74.8% during the fourth quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock valued at $65,912,000 after buying an additional 377,705 shares during the last quarter. Reinhart Partners LLC. grew its holdings in Maximus by 65.4% during the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock valued at $62,156,000 after buying an additional 360,365 shares in the last quarter. Finally, Squarepoint Ops LLC bought a new stake in Maximus in the 4th quarter worth approximately $22,661,000. 97.21% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

View Our Latest Stock Report on MMS

Insider Buying and Selling at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director owned 14,205 shares in the company, valued at $1,028,157.90. The trade was a 35.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.60% of the company's stock.

Maximus Trading Down 3.4%

Shares of NYSE:MMS traded down $2.46 during trading on Tuesday, hitting $69.91. The company had a trading volume of 553,855 shares, compared to its average volume of 572,705. The stock has a market cap of $3.94 billion, a price-to-earnings ratio of 13.90 and a beta of 0.61. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.84 and a quick ratio of 1.84. The company has a fifty day simple moving average of $71.65 and a two-hundred day simple moving average of $70.90. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period last year, the company earned $1.57 earnings per share. Maximus's revenue was up 1.0% on a year-over-year basis. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.72%. Maximus's dividend payout ratio is 23.86%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

See Also

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines